{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:11:41Z","timestamp":1788930701671,"version":"build-2803163510"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Worldwide Antimalarial Resistance Network, Oxford, UK"},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Independent emergence and spread of artemisinin-resistant <jats:italic>Plasmodium falciparum <\/jats:italic>malaria have recently been confirmed in Africa, with molecular markers associated with artemisinin resistance increasingly detected. Surveillance to promptly detect and effectively respond to anti-malarial resistance is generally suboptimal in Africa, especially in low transmission settings where therapeutic efficacy studies are often not feasible due to recruitment challenges. However,\u00a0these communities may be at higher risk of anti-malarial resistance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From March 2018 to February 2020, a sequential mixed-methods study was conducted to evaluate the feasibility of the near-real-time linkage of individual patient anti-malarial resistance profiles with their case notifications and treatment response reports, and map these to fine scales in Nkomazi sub-district, Mpumalanga, a pre-elimination area in South Africa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>Plasmodium falciparum<\/jats:italic> molecular marker resistance profiles were linked to 55.1% (2636\/4787) of notified malaria cases, 85% (2240\/2636) of which were mapped to healthcare facility, ward and locality levels. Over time, linkage of individual malaria case demographic and molecular data increased to 75.1%. No artemisinin resistant validated\/associated <jats:italic>\u00a0Kelch-13<\/jats:italic> mutations were detected in the 2385 PCR positive samples. Almost all 2812 samples assessed for lumefantrine susceptibility carried the wildtype <jats:italic>mdr<\/jats:italic>86ASN and <jats:italic>crt<\/jats:italic>76LYS alleles, potentially associated with decreased lumefantrine susceptibility.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Routine near-real-time mapping of molecular markers associated with anti-malarial drug resistance on a fine spatial scale provides a rapid and efficient early warning system for emerging resistance. The lessons learnt here could inform scale-up to provincial, national and regional malaria elimination programmes, and may be relevant for other antimicrobial resistance surveillance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-022-04224-4","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T16:02:56Z","timestamp":1656518576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Making data map-worthy\u2014enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study"],"prefix":"10.1186","volume":"21","author":[{"given":"Frank M.","family":"Kagoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Mabuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Workman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Magagula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerdalize","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Malatje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe J.","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Dhorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Maude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishree","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen I.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"4224_CR1","first-page":"2020","volume-title":"World malaria report 2020: 20 years of global progress and challenges","author":"WHO","year":"2020","unstructured":"WHO. World malaria report 2020: 20 years of global progress and challenges. Geneva: World Health Organization; 2020. p. 2020."},{"key":"4224_CR2","first-page":"2018","volume-title":"World malaria report 2018","author":"WHO","year":"2018","unstructured":"WHO. World malaria report 2018. Geneva: World Health Organization; 2018. p. 2018."},{"key":"4224_CR3","first-page":"2021","volume-title":"World malaria report 2021","author":"WHO","year":"2021","unstructured":"WHO. World malaria report 2021. Geneva: World Health Organization; 2021. p. 2021."},{"key":"4224_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"4224_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"15","author":"KM Tun","year":"2015","unstructured":"Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:415\u201321.","journal-title":"Lancet Infect Dis"},{"key":"4224_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fpubh.2019.00095","volume":"7","author":"J Feng","year":"2019","unstructured":"Feng J, Kong X, Xu D, Yan H, Zhou H, Tu H, et al. Investigation and evaluation of genetic diversity of Plasmodium falciparum kelch 13 polymorphisms imported from Southeast Asia and Africa in Southern China. Front Public Health. 2019;7:95.","journal-title":"Front Public Health"},{"key":"4224_CR7","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/cid\/ciy1038","volume":"69","author":"S Das","year":"2019","unstructured":"Das S, Manna S, Saha B, Hati AK, Roy S. Novel pfkelch13 gene polymorphism associates with artemisinin resistance in Eastern India. Clin Infect Dis. 2019;69:1144\u201352.","journal-title":"Clin Infect Dis"},{"key":"4224_CR8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.7196\/SAMJ.7441","volume":"103","author":"R Maharaj","year":"2013","unstructured":"Maharaj R, Raman J, Morris N, Moonasar D, Durrheim DN, Seocharan I, et al. Epidemiology of malaria in South Africa: from control to elimination. South African Med J. 2013;103:779\u201383.","journal-title":"South African Med J"},{"key":"4224_CR9","volume-title":"Elimination 8. SADC malaria elimination eight regional surveillance quarterly bulletin: malaria incidence along E8 border districts","author":"SADC","year":"2020","unstructured":"SADC. Elimination 8. SADC malaria elimination eight regional surveillance quarterly bulletin: malaria incidence along E8 border districts. Windhoek: Namibia; 2020."},{"key":"4224_CR10","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum k13-propeller polymorphisms. N Engl J Med. 2016;374:2453\u201364.","journal-title":"N Engl J Med"},{"key":"4224_CR11","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/s41598-020-60549-7","volume":"10","author":"GM Bwire","year":"2020","unstructured":"Bwire GM, Ngasala B, Mikomangwa WP, Kilonzi M, Kamuhabwa AAR. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania. Sci Rep. 2020;10:3500.","journal-title":"Sci Rep"},{"key":"4224_CR12","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH, Mangala Ndikumana J-L, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26:1602\u20138.","journal-title":"Nat Med"},{"key":"4224_CR13","doi-asserted-by":"publisher","first-page":"e02550","DOI":"10.1128\/AAC.02550-18","volume":"63","author":"MA Pacheco","year":"2019","unstructured":"Pacheco MA, Kadakia ER, Chaudhary Z, Perkins DJ, Kelley J, Ravishankar S, et al. Evolution and genetic diversity of the k13 gene associated with artemisinin delayed parasite clearance in Plasmodium falciparum. Antimicrob Agents Chemother. 2019;63:e02550-e2618.","journal-title":"Antimicrob Agents Chemother"},{"key":"4224_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s13104-020-05334-5","volume":"13","author":"M Tola","year":"2020","unstructured":"Tola M, Ajibola O, Idowu ET, Omidiji O, Awolola ST, Amambua-Ngwa A. Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest. Nigeria BMC Res Notes. 2020;13:497.","journal-title":"Nigeria BMC Res Notes"},{"key":"4224_CR15","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis. 2021;21:1120\u20138.","journal-title":"Lancet Infect Dis"},{"key":"4224_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana S-I, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"4224_CR17","volume-title":"WHO Malaria Policy Advisory Group (MPAG) meeting","author":"Global Malaria Programe","year":"2021","unstructured":"Global Malaria Programe. WHO Malaria Policy Advisory Group (MPAG) meeting. Geneva: World Health Organization; 2021."},{"key":"4224_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer J, Gn\u00e4dig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347:428\u201331.","journal-title":"Science"},{"key":"4224_CR19","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/infdis\/jiv752","volume":"213","author":"SM Chenet","year":"2016","unstructured":"Chenet SM, Akinyi Okoth S, Huber CS, Chandrabose J, Lucchi NW, Talundzic E, et al. Independent emergence of the Plasmodium falciparum Kelch propeller domain mutant allele C580Y in Guyana. J Infect Dis. 2016;213:1472\u20135.","journal-title":"J Infect Dis"},{"key":"4224_CR20","doi-asserted-by":"publisher","first-page":"e51015","DOI":"10.7554\/eLife.51015","volume":"9","author":"LC Mathieu","year":"2020","unstructured":"Mathieu LC, Cox H, Early AM, Mok S, Lazrek Y, Paquet J-C, et al. Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance. Elife. 2020;9:e51015.","journal-title":"Elife"},{"key":"4224_CR21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.4269\/ajtmh.19-0954","volume":"102","author":"MJ Olivera","year":"2020","unstructured":"Olivera MJ, Guerra AP, Cortes LJ, Horth RZ, Padilla J, Novoa J, et al. Artemether\u2013lumefantrine efficacy for the treatment of uncomplicated Plasmodium falciparum malaria in Choco, Colombia after 8 years as first-line treatment. Am J Trop Med Hyg. 2020;102:1056\u201363.","journal-title":"Am J Trop Med Hyg"},{"key":"4224_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","volume":"16","author":"L Ndwiga","year":"2021","unstructured":"Ndwiga L, Kimenyi KM, Wamae K, Osoti V, Akinyi M, Omedo I, et al. A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa. Int J Parasitol Drugs Drug Resist. 2021;16:155\u201361.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"4224_CR23","volume-title":"A framework for malaria elimination","author":"WHO","year":"2017","unstructured":"WHO. A framework for malaria elimination. Geneva: World Health Organization; 2017."},{"key":"4224_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.46234\/ccdcw2021.099","volume":"3","author":"F Huang","year":"2021","unstructured":"Huang F, Liu H, Yan H, Zhou S, Xia Z. Antimalarial drug resistance surveillance in China, 2016\u20132020. China CDC Wkly. 2021;3:366.","journal-title":"China CDC Wkly"},{"key":"4224_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12936-021-03791-2","volume":"20","author":"P Sudathip","year":"2021","unstructured":"Sudathip P, Saejeng A, Khantikul N, Thongrad T, Kitchakarn S, Sugaram R, et al. Progress and challenges of integrated drug efficacy surveillance for uncomplicated malaria in Thailand. Malar J. 2021;20:261.","journal-title":"Malar J"},{"key":"4224_CR26","first-page":"2018","volume-title":"Malaria surveillance, monitoring & evaluation: a reference manual","author":"WHO","year":"2018","unstructured":"WHO. Malaria surveillance, monitoring & evaluation: a reference manual. Geneva: World Health Organization; 2018. p. 2018."},{"key":"4224_CR27","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1016\/S2666-5247(21)00249-4","volume":"3","author":"FM Kagoro","year":"2022","unstructured":"Kagoro FM, Barnes KI, Marsh K, Ekapirat N, Mercado CEG, Sinha I, et al. Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis. Lancet Microbe. 2022;3:e184\u201392.","journal-title":"Lancet Microbe"},{"key":"4224_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12936-019-2911-y","volume":"18","author":"J Raman","year":"2019","unstructured":"Raman J, Kagoro FM, Mabuza A, Malatje G, Reid A, Frean J, et al. Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001\u20132018). Malar J. 2019;18:280.","journal-title":"Malar J"},{"key":"4224_CR29","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.4269\/ajtmh.17-0021","volume":"97","author":"M Ndiaye","year":"2017","unstructured":"Ndiaye M, Sow D, Nag S, Sylla K, Tine CR, Jean NL, et al. Country-wide surveillance of molecular markers of antimalarial drug resistance in Senegal by use of positive malaria rapid diagnostic tests. Am J Trop Med Hyg. 2017;97:1593\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"4224_CR30","doi-asserted-by":"publisher","first-page":"e62997","DOI":"10.7554\/eLife.62997","volume":"10","author":"CG Jacob","year":"2021","unstructured":"Jacob CG, Thuy-Nhien N, Mayxay M, Maude RJ, Quang HH, Hongvanthong B, et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. Elife. 2021;10:e62997.","journal-title":"Elife"},{"key":"4224_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.12688\/wellcomeopenres.15164.1","volume":"4","author":"RJ Maude","year":"2019","unstructured":"Maude RJ, Mercado CEG, Rowley J, Ekapirat N, Dondorp A. Estimating malaria disease burden in the Asia-Pacific. Wellcome Open Res. 2019;4:59.","journal-title":"Wellcome Open Res"},{"key":"4224_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5195\/jmla.2017.109","volume":"105","author":"J Barr-Walker","year":"2017","unstructured":"Barr-Walker J. Evidence-based information needs of public health workers: a systematized review. J Med Libr Assoc. 2017;105:69\u201379.","journal-title":"J Med Libr Assoc"},{"key":"4224_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-13-297","volume":"13","author":"SP Silal","year":"2014","unstructured":"Silal SP, Little F, Barnes KI, White LJ. Towards malaria elimination in Mpumalanga, South Africa: a population-level mathematical modelling approach. Malar J. 2014;13:297.","journal-title":"Malar J"},{"key":"4224_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0169-4758(96)30032-X","volume":"12","author":"RW Snow","year":"1996","unstructured":"Snow RW, Marsh K, Le Sueur D. The need for maps of transmission intensity to guide malaria control in Africa. Parasitol Today. 1996;12:455\u20137.","journal-title":"Parasitol Today"},{"key":"4224_CR35","first-page":"44","volume":"202","author":"M Mera","year":"2014","unstructured":"Mera M, Gonzalez C, Lopez DM. Towards an intelligent decision support system for public health surveillance\u2014a qualitative analysis of information needs. Stud Health Technol Inform. 2014;202:44\u20137.","journal-title":"Stud Health Technol Inform"},{"key":"4224_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jbi.2014.04.006","volume":"51","author":"LN Carroll","year":"2014","unstructured":"Carroll LN, Au AP, Todd Detwiler L, Fu T, Painter IS, Abernethy NF. Visualization and analytics tools for infectious disease epidemiology: a systematic review. J Biomed Inform. 2014;51:287\u201398.","journal-title":"J Biomed Inform"},{"key":"4224_CR37","unstructured":"NICD. National guidelines for the treatment of malaria, South Africa 2018 (Updated January 2019). Pretoria, 2019."},{"key":"4224_CR38","unstructured":"National Department of Health (NDOH). Republic of South Africa Malaria Elimination Strategic Plan 2019\u20132023. Pretoria, South Africa, 2019."},{"key":"4224_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/env.507","volume":"13","author":"C Libiseller","year":"2002","unstructured":"Libiseller C, Grimvall A. Performance of partial Mann-Kendall tests for trend detection in the presence of covariates. Environmetrics. 2002;13:71\u201384.","journal-title":"Environmetrics"},{"key":"4224_CR40","unstructured":"Silverman BW. Density estimation for statistics and data analysis. In: Monographs on statistics and applied probability. London, UK: Chapman and Hall; 1986. p. 1\u201322."},{"key":"4224_CR41","unstructured":"Statistics South Africa. Census 2011, Statistical release (Revised). Pretoria, South Africa, 2011."},{"key":"4224_CR42","first-page":"83","volume":"86","author":"BL Sharp","year":"1996","unstructured":"Sharp BL, le Sueur D. Malaria in South Africa\u2013the past, the present and selected implications for the future. S Afr Med J. 1996;86:83\u20139.","journal-title":"S Afr Med J"},{"key":"4224_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/1475-2875-11-423","volume":"11","author":"R Maharaj","year":"2012","unstructured":"Maharaj R, Morris N, Seocharan I, Kruger P, Moonasar D, Mabuza A, et al. The feasibility of malaria elimination in South Africa. Malar J. 2012;11:423.","journal-title":"Malar J"},{"key":"4224_CR44","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/infdis\/jiaa498","volume":"225","author":"K Stepniewska","year":"2022","unstructured":"Stepniewska K, Humphreys GS, Gon\u00e7alves BP, Craig E, Gosling R, Guerin PJ, et al. Efficacy of single dose primaquine with artemisinin combination therapy on P. falciparum gametocytes and transmission: a WWARN individual patient meta-analysis. J Infect Dis. 2022;225:1215\u201326.","journal-title":"J Infect Dis"},{"key":"4224_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12916-017-0990-6","volume":"16","author":"WR Taylor","year":"2018","unstructured":"Taylor WR, Naw HK, Maitland K, Williams TN, Kapulu M, D\u2019Alessandro U, et al. Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria\u2014a proposed model-derived age-based regimen for sub-Saharan Africa. BMC Med. 2018;16:11.","journal-title":"BMC Med"},{"key":"4224_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12936-019-2841-8","volume":"18","author":"J Raman","year":"2019","unstructured":"Raman J, Allen E, Workman L, Mabuza A, Swanepoel H, Malatje G, et al. Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial. Malar J. 2019;18:209.","journal-title":"Malar J"},{"key":"4224_CR47","unstructured":"Barnes K, Mabuza A, Frean PJ, Magagula R, Bridget M, Guerin P. Smart surveillance towards malaria elimination in Mpumalanga, South Africa (SS4ME): novel approaches for mapping antimalarial resistance. WWARN (Protocol). 2017."},{"key":"4224_CR48","unstructured":"University of Waterloo Geospatial Centre. Geospatial Administrative Areas (GADM) version 4.0.4, https:\/\/gadm.org\/download_country.html. Accessed 1 May 2022."},{"key":"4224_CR49","unstructured":"Centre for Humanitarian Data. Humanitarian Data Exchange, https:\/\/data.humdata.org\/. Accessed 12 May 2021."},{"key":"4224_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1179\/000349803125002977","volume":"97","author":"D Padley","year":"2003","unstructured":"Padley D, Moody AH, Chiodini PL, Saldanha J. Use of a rapid, single-round, multiplex PCR to detect malarial parasites and identify the species present. Ann Trop Med Parasitol. 2003;97:131\u20137.","journal-title":"Ann Trop Med Parasitol"},{"key":"4224_CR51","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/jac\/dkm104","volume":"59","author":"CJ Sutherland","year":"2007","unstructured":"Sutherland CJ, Haustein T, Gadalla N, Armstrong M, Doherty JF, Chiodini PL. Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis. J Antimicrob Chemother. 2007;59:1197\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"4224_CR52","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann A-C, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438\u201347.","journal-title":"Lancet"},{"key":"4224_CR53","doi-asserted-by":"publisher","first-page":"e0136099","DOI":"10.1371\/journal.pone.0136099","volume":"10","author":"E Talundzic","year":"2015","unstructured":"Talundzic E, Chenet SM, Goldman IF, Patel DS, Nelson JA, Plucinski MM, et al. Genetic analysis and species specific amplification of the artemisinin resistance-associated kelch propeller domain in P. falciparum and P. vivax. PLoS ONE. 2015;10:e0136099.","journal-title":"PLoS ONE"},{"key":"4224_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-018-1207-3","volume":"17","author":"WWARN K13 Genotype-Phenotype Study Group","year":"2019","unstructured":"WWARN K13 Genotype-Phenotype Study Group. Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis. BMC Med. 2019;17:1.","journal-title":"BMC Med"},{"key":"4224_CR55","volume-title":"A language and environment for statistical computing","author":"R Core Team","year":"2020","unstructured":"R Core Team. A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2020."},{"key":"4224_CR56","unstructured":"Pohlert T. Non-Parametric Trend Tests and Change-Point Detection [R package trend version 1.1.4]. https:\/\/CRAN.R-project.org\/package=trend. Accessed 01 May 2022"},{"key":"4224_CR57","volume-title":"Status report on artemisinin and ACT","author":"WHO","year":"2017","unstructured":"WHO. Artemisinin and artemisinin-based\ncombination therapy resistance: Status Report. Geneva: World Health Organization; 2017."},{"key":"4224_CR58","volume-title":"Report on antimalarial drug efficacy, resistance and response 10 years of surveillance (2010\u20132019)","author":"WHO","year":"2020","unstructured":"WHO. Report on antimalarial drug efficacy, resistance and response 10 years of surveillance (2010\u20132019). Geneva: World Health Organization; 2020."},{"key":"4224_CR59","unstructured":"Department of Rural Development and Land. The South African Coordinate Reference System. Pretoria, South Africa, 2019."},{"key":"4224_CR60","doi-asserted-by":"crossref","unstructured":"Shretta R, Liu J, Cotter C, Cohen J, Dolenz C, Makomva K, et al. Malaria elimination and eradication. In: Disease Control Priorities, Third Edition (Volume 6); Major Infectious Diseases. Washington, DC: The International Bank for Reconstruction and Development \/ The World Bank; 2017.","DOI":"10.1596\/978-1-4648-0524-0_ch12"},{"key":"4224_CR61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12936-018-2185-9","volume":"17","author":"C Nsanzabana","year":"2018","unstructured":"Nsanzabana C, Djalle D, Gu\u00e9rin PJ, M\u00e9nard D, Gonz\u00e1lez IJ. Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape. Malar J. 2018;17:75.","journal-title":"Malar J"},{"key":"4224_CR62","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.3390\/ijerph110505170","volume":"11","author":"H Chen","year":"2014","unstructured":"Chen H, Hailey D, Wang N, Yu P. A review of data quality assessment methods for public health information systems. Int J Environ Res Public Health. 2014;11:5170\u2013207.","journal-title":"Int J Environ Res Public Health"},{"key":"4224_CR63","unstructured":"WHO. Data Quality Review (DQR) Toolkit. Geneva, World Health Organization. https:\/\/www.who.int\/healthinfo\/tools_data_analysis\/dqr_modules\/en\/. Accessed 14 Jan 2020."},{"key":"4224_CR64","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12936-019-2972-y","volume":"18","author":"TT Nguyen","year":"2019","unstructured":"Nguyen TT, Nzigou Mombo B, Lalremruata A, Koehne E, Zoleko Manego R, Dimessa Mbadinga LB, et al. DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambar\u00e9n\u00e9. Gabon Malar J. 2019;18:336.","journal-title":"Gabon Malar J"},{"key":"4224_CR65","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1475-2875-12-106","volume":"12","author":"U Morris","year":"2013","unstructured":"Morris U, Aydin-Schmidt B, Shakely D, M\u00e5rtensson A, J\u00f6rnhagen L, Ali AS, et al. Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria\u2014assessment of DNA extraction methods and field applicability. Malar J. 2013;12:106.","journal-title":"Malar J"},{"key":"4224_CR66","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2875-10-6","volume":"10","author":"DS Ishengoma","year":"2011","unstructured":"Ishengoma DS, Lwitiho S, Madebe RA, Nyagonde N, Persson O, Vestergaard LS, et al. Using rapid diagnostic tests as source of malaria parasite DNA for molecular analyses in the era of declining malaria prevalence. Malar J. 2011;10:6.","journal-title":"Malar J"},{"key":"4224_CR67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1475-2875-10-67","volume":"10","author":"L Cnops","year":"2011","unstructured":"Cnops L, Boderie M, Gillet P, Van Esbroeck M, Jacobs J. Rapid diagnostic tests as a source of DNA for Plasmodium species-specific real-time PCR. Malar J. 2011;10:67.","journal-title":"Malar J"},{"key":"4224_CR68","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12936-019-2880-1","volume":"18","author":"SK Tessema","year":"2019","unstructured":"Tessema SK, Raman J, Duffy CW, Ishengoma DS, Amambua-Ngwa A, Greenhouse B. Applying next-generation sequencing to track falciparum malaria in sub-Saharan Africa. Malar J. 2019;18:268.","journal-title":"Malar J"},{"key":"4224_CR69","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/infdis\/jit392","volume":"208","author":"SM Taylor","year":"2013","unstructured":"Taylor SM, Parobek CM, Aragam N, Ngasala BE, M\u00e5rtensson A, Meshnick SR, et al. Pooled deep sequencing of Plasmodium falciparum isolates: an efficient and scalable tool to quantify prevailing malaria drug-resistance genotypes. J Infect Dis. 2013;208:1998\u20132006.","journal-title":"J Infect Dis"},{"key":"4224_CR70","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12936-019-2986-5","volume":"18","author":"SAS Diakit\u00e9","year":"2019","unstructured":"Diakit\u00e9 SAS, Traor\u00e9 K, Sanogo I, Clark TG, Campino S, Sangar\u00e9 M, et al. A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali. Malar J. 2019;18:361.","journal-title":"Malar J"},{"key":"4224_CR71","unstructured":"WHO. Malaria Threat Map. Geneva, World Health Organization. https:\/\/apps.who.int\/malaria\/maps\/threats\/. Accessed 26 Aug 2020."},{"key":"4224_CR72","doi-asserted-by":"publisher","first-page":"e0191922","DOI":"10.1371\/journal.pone.0191922","volume":"13","author":"V Baraka","year":"2018","unstructured":"Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, et al. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda. PLoS ONE. 2018;13:e0191922.","journal-title":"PLoS ONE"},{"key":"4224_CR73","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","volume":"91","author":"M Venkatesan","year":"2014","unstructured":"Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg. 2014;91:833\u201343.","journal-title":"Am J Trop Med Hyg"},{"key":"4224_CR74","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12936-018-2233-5","volume":"17","author":"D Ljolje","year":"2018","unstructured":"Ljolje D, Dimbu PR, Kelley J, Goldman I, Nace D, Macaia A, et al. Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015. Malar J. 2018;17:84.","journal-title":"Malar J"},{"key":"4224_CR75","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12936-018-2290-9","volume":"17","author":"E Davlantes","year":"2018","unstructured":"Davlantes E, Dimbu PR, Ferreira CM, Florinda MJ, Pode D, F\u00e9lix J, et al. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Malar J. 2018;17:144.","journal-title":"Malar J"},{"key":"4224_CR76","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12936-021-03585-6","volume":"20","author":"A Gansan\u00e9","year":"2021","unstructured":"Gansan\u00e9 A, Moriarty LF, M\u00e9nard D, Yerbanga I, Ouedraogo E, Sondo P, et al. Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso 2017\u20132018. Malar J. 2021;20:48.","journal-title":"Malar J"},{"key":"4224_CR77","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12936-020-03376-5","volume":"19","author":"Y Wu","year":"2010","unstructured":"Wu Y, Soe MT, Aung PL, Zhao L, Zeng W, Menezes L, et al. Efficacy of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum cases and molecular surveillance of drug resistance genes in Western Myanmar. Malar J. 2010;19:304.","journal-title":"Malar J"},{"key":"4224_CR78","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12916-020-1494-3","volume":"18","author":"MT Bretscher","year":"2020","unstructured":"Bretscher MT, Dahal P, Griffin J, Stepniewska K, Bassat Q, Baudin E, et al. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data. BMC Med. 2020;18:47.","journal-title":"BMC Med"},{"key":"4224_CR79","first-page":"e01949","volume":"65","author":"PR Dimbu","year":"2021","unstructured":"Dimbu PR, Horth R, C\u00e2ndido ALM, Ferreira CM, Caquece F, Garcia LEA, et al. Continued low efficacy of artemether-lumefantrine in Angola in 2019. Antimicrob Agents Chemother. 2021;65:e01949-e2020.","journal-title":"Antimicrob Agents Chemother"},{"key":"4224_CR80","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"MD Conrad","year":"2019","unstructured":"Conrad MD, Rosenthal PJ. Antimalarial drug resistance in Africa: the calm before the storm? Lancet Infect Dis. 2019;19:e338\u201351.","journal-title":"Lancet Infect Dis"},{"key":"4224_CR81","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12936-018-2290-9","volume":"17","author":"E Davlantes","year":"2018","unstructured":"Davlantes E, Dimbu PR, Ferreira CM, Florinda Joao M, Pode D, F\u00e9lix J, et al. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Malar J. 2018;17:144.","journal-title":"Malar J"},{"key":"4224_CR82","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12936-018-2451-x","volume":"17","author":"RE Baloyi","year":"2018","unstructured":"Baloyi RE, Shandukani MB, Graffy R, Misiani E, Mayet N, Mabunda E, et al. Evaluating a 24-h mobile reporting system for malaria notifications in comparison with a paper-based system in South Africa, 2015. Malar J. 2018;17:308.","journal-title":"Malar J"},{"key":"4224_CR83","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12936-017-1973-y","volume":"16","author":"S Githinji","year":"2017","unstructured":"Githinji S, Oyando R, Malinga J, Ejersa W, Soti D, Rono J, et al. Completeness of malaria indicator data reporting via the District Health Information Software 2 in Kenya, 2011\u20132015. Malar J. 2017;16:344.","journal-title":"Malar J"},{"key":"4224_CR84","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12911-020-01315-7","volume":"20","author":"MB Gesicho","year":"2020","unstructured":"Gesicho MB, Were MC, Babic A. Data cleaning process for HIV-indicator data extracted from DHIS2 national reporting system: a case study of Kenya. BMC Med Inform Decis Mak. 2020;20:293.","journal-title":"BMC Med Inform Decis Mak"},{"key":"4224_CR85","doi-asserted-by":"publisher","first-page":"e0211265","DOI":"10.1371\/journal.pone.0211265","volume":"14","author":"AA Bhattacharya","year":"2019","unstructured":"Bhattacharya AA, Umar N, Audu A, Allen E, Schellenberg JRM, Marchant T. Quality of routine facility data for monitoring priority maternal and newborn indicators in DHIS2: a case study from Gombe State Nigeria. PLoS ONE. 2019;14:e0211265.","journal-title":"PLoS ONE"},{"key":"4224_CR86","volume-title":"World malaria report","author":"WHO","year":"2016","unstructured":"WHO. World malaria report 2016. Geneva: World Health Organization; 2016."},{"key":"4224_CR87","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1108\/S1474-8231(2012)0000012006","volume":"12","author":"DR Hotchkiss","year":"2012","unstructured":"Hotchkiss DR, Diana ML, Foreit KGF. How can routine health information systems improve health systems functioning in lowand middle-income countries? assessing the evidence base. Adv Health Care Manag. 2012;12:25\u201358.","journal-title":"Adv Health Care Manag"},{"key":"4224_CR88","volume-title":"World malaria report 2019","author":"WHO","year":"2019","unstructured":"WHO. World malaria report 2019. Geneva: World Health Organization; 2019."},{"key":"4224_CR89","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12942-021-00262-4","volume":"20","author":"E Hyde","year":"2021","unstructured":"Hyde E, Bonds MH, Ihantamalala FA, Miller AC, Cordier LF, Razafinjato B, et al. Estimating the local spatio-temporal distribution of malaria from routine health information systems in areas of low health care access and reporting. Int J Health Geogr. 2021;20:8.","journal-title":"Int J Health Geogr"},{"key":"4224_CR90","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.4269\/ajtmh.20-0833","volume":"103","author":"KES Hamre","year":"2020","unstructured":"Hamre KES, Pierre B, Namuyinga R, Mace K, Rogier EW, Udhayakumar V, et al. Establishing a national molecular surveillance program for the detection of Plasmodium falciparum markers of resistance to antimalarial drugs in Haiti. Am J Trop Med Hyg. 2020;103:2217\u201323.","journal-title":"Am J Trop Med Hyg"},{"key":"4224_CR91","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1590\/0074-0276140067","volume":"109","author":"GA Fontecha","year":"2014","unstructured":"Fontecha GA, Sanchez AL, Mendoza M, Banegas E, Mej\u00eda-Torres RE. A four-year surveillance program for detection of Plasmodium falciparum chloroquine resistance in Honduras. Mem Inst Oswaldo Cruz. 2014;109:492\u20133.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"4224_CR92","unstructured":"GenRe-Mekong. Genomic Epidemiology Network (MalariaGen), https:\/\/www.malariagen.net\/parasite\/genre-mekong. Accessed 17 Feb 2022."},{"issue":"4","key":"4224_CR93","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1365-2958.2005.04729.x","volume":"57","author":"Amar Bir Singh Sidhu","year":"2005","unstructured":"Sidhu AB, Valderramos SG, Fidock DA. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol. 2005; 57(4):913-926","journal-title":"Molecular Microbiology"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04224-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T19:04:33Z","timestamp":1656529473000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04224-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4224"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04224-4","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"2 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Human Research Ethics Committee of the Faculty of Health Sciences at the University of Cape Town (HREC REF Number: 698\/2019), including data obtained in the SS4ME project (HREC REF Number: 519\/2017). SS4ME was endorsed by the South African Department of Health, the NICD and the Mpumalanga Malaria Elimination Programme. All governmental and non-governmental partners were notified, and their programme staff informed, including malaria elimination programme staff, information officers, clinicians, and data clerks.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"207"}}